Insights

Perspectives on quality, compliance & regulation

Practical guidance from our specialists on the issues shaping pharmaceutical quality and regulatory affairs.

Annex 1 & the Contamination Control Strategy: What Sterile Sites Must Do Now

The revised EU GMP Annex 1 made the Contamination Control Strategy central — and a folder of existing SOPs is not one. How to build a holistic, living CCS that holds up under inspection.

Jun 5, 2026Read

CSV

7 min

Computer Software Assurance (CSA): Doing Less Validation, Better

CSA and GAMP 5 Second Edition replace documentation volume with risk-based assurance. How to focus validation effort where it actually protects product quality and data integrity.

May 30, 2026Read

GxP

8 min

GMP Compliance Essentials: Building a Quality System That Passes Inspection

What separates sites that breeze through inspections from those that struggle? A practical look at the GMP fundamentals — from data integrity to CAPA effectiveness — that inspectors actually probe.

May 20, 2026Read

GxP

7 min

Surviving an FDA 483 or Warning Letter: A Remediation Playbook

The difference between a site that recovers and one that spirals is decided in the first few weeks. A practical playbook for credible, durable remediation — to demonstrable closure.

May 12, 2026Read

Pharmacovigilance

7 min

AI in Pharmacovigilance: Smarter Signal Detection Without Losing Control

AI-assisted methods can screen vast safety datasets far faster than manual review — but only a disciplined, GVP-aligned process keeps the human judgment regulators expect. Here's how to adopt it responsibly.

Apr 28, 2026Read

Regulatory Affairs

6 min

eCTD Submissions: Getting It Right the First Time

A well-built eCTD dossier means fewer deficiency letters and a faster approval. We break down the publishing, granularity and validation practices that keep submissions out of the rejection pile.

Apr 10, 2026Read

Quality & Compliance

7 min

Nitrosamines and the Modern Impurity Control Strategy

Nitrosamines stress-tested the industry's impurity control discipline. How ICH M7 and Q3 frame a structured, risk-based control strategy — from source mapping to justification.

Mar 25, 2026Read

GxP

7 min

Choosing a CMO: A Practical Qualification & Technology-Transfer Checklist

CMO partnerships are won or lost before the first batch. A practical checklist for qualifying the CMO and running a technology transfer that preserves process control.

Mar 8, 2026Read

Ready to improve your compliance?

Talk to an independent PharmExpert specialist about your GxP, regulatory or quality challenge. We respond within one business day.

Request an Audit +91 70468 82130